EYEN: Eyenovia, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 44.56
Enterprise Value ($M) 44.00
Book Value ($M) 9.00
Book Value / Share 0.18
Price / Book 4.95
NCAV ($M) 0.93
NCAV / Share 0.02
Price / NCAV 48.10

Profitability (mra)
Return on Invested Capital (ROIC) -1.09
Return on Assets (ROA) -0.93
Return on Equity (ROE) -1.72

Liquidity (mrq)
Quick Ratio 2.16
Current Ratio 2.17

Balance Sheet (mrq) ($M)
Current Assets 20.71
Assets 28.78
Liabilities 19.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.41
Net Income -27.26
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -23.84
Cash from Investing -3.97
Cash from Financing 19.79

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Armistice Capital, Llc 9.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-07 229,045 82,888 276.33
2024-05-06 662,217 267,763 247.31
2024-05-03 619,807 2,484,767 24.94
2024-05-02 338,945 127,967 264.87

(click for more detail)

Similar Companies
ERNA – Eterna Therapeutics Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc. FBIO – Fortress Biotech, Inc.
FBRX – Forte Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io